… top-selling drug, overtaking GSK’s widely used antibiotic Augmentin. Mounjaro was … consumers significantly more for basic medicines, something Trump has pledged to … -molecule drugs or biologics. Twenty-four of the top 25 pharmaceutical companies …

… postings on the FDA’s dedicated drug recall page, … drug is released from a dosage form like a pill … stimulant ADHD medication Vyvanse. Elsewhere, Teva Pharmaceuticals recently embarked … a combination antibiotic referencing Augmentin—after the clavulanate …

… also lack these medicines. The medicine is available at … acid (Augmentin) 1.2g for injection, another essential medication, was … the medicines for cancer patients. If such drugs are … care, increased costs, medication errors, and potential adverse …

… that month in the Indian Pharmaceutical Market (IPM). This … traditional market leaders such as Augmentin, which posted around ₹ … diabetes and obesity patients. Medical Dialogues had earlier reported … in India’s diabetes treatment market from traditional oral …

… of a critical drug for general anesthesia Augmentin XR for domestic … distributed to companies developing treatments that address urgent domestic … as increasing US-based drug manufacturing. Medications that use Most … with a team of doctors on major life-and- …

… become India’s highest-selling pharmaceutical brand in October, according to … leader Augmentin, the antibiotic that traditionally dominates India’s monthly drug sales … massive—an Indian Council of Medical Research-Madras Diabetes Research Foundation …

… in October. However, volumewise Augmentin outsold Mounjaro. It sold 58 … down digestion. Cost of treatment in India Mounjaro could cost … prices of their GLP-1 drugs for US government programs. … reportedly prompted many Indian drugmakers to develop their own …

… GLP-1 medications Orforglipron, Lilly's investigational obesity pill, and … positive lung cancer treatment, zongertinib. Launched by FDA Commissioner Marty Markary … drug from Revolution Medicine; bitopertin, a treatment for rare blood diseases; Augmentin …

… has surpassed GSK’s antibiotic Augmentin—which stood at Rs 80 … injectables—Mounjaro and Wegovy—the drug volume tanked from 1.47 … -molecule pill, Orforglipron, which is set to undergo Phase 3 trials in … because the entire class of treatment is new and there will …

… vice-president, commercial, Pharmarack. Augmentin has held on to the … Tirzepatide is a prescription drug that activates both glucose- … to enter. Several top drugmakers in the country, including … copycat versions, of the drug. Generic drugs will be launched at …